Changes in growth hormone receptor gene expression during therapy in children with juvenile idiopathic arthritis

Horm Res Paediatr. 2012;77(1):52-8. doi: 10.1159/000334646. Epub 2011 Dec 24.

Abstract

Background: High levels of cytokines in juvenile idiopathic arthritis (JIA) can alter target cell sensitivity to growth hormone (GH) leading to short stature in adulthood. We hypothesized that the down-regulation of GH receptor (GHR) gene expression could be involved in growth failure of children with JIA.

Methods: In 18 (12 F and 6 M) prepubertal JIA patients and 13 age- and sex-matched healthy children, we evaluated serum growth-promoting factors and inflammatory indexes. We also measured GHR gene expression, by real-time PCR, in lymphocytes of patients and controls. All parameters were evaluated in patients before and after treatment of JIA.

Results: The most interesting (p = 0.007) result was the increase in GHR mRNA expression in all JIA patients. Moreover, we observed a significant (p = 0.0156) decrease in IL-6 levels in JIA patients after 2 years of therapy (19.37 ± 41.01) with respect to basal values (90.84 ± 124.71). On the contrary, IGF-I significantly (p = 0.0005) increased to a mean SDS value of 0 (range -1.69 to +1.70 SDS) with respect to values at disease onset (-0.64 SDS).

Conclusions: Our preliminary data suggest that the restoration of both GHR gene expression and IGF-I secretion correlate with inactive disease in JIA children.

MeSH terms

  • Anthropometry
  • Arthritis, Juvenile / metabolism*
  • Arthritis, Juvenile / therapy
  • Case-Control Studies
  • Child
  • Female
  • Gene Expression
  • Humans
  • Insulin-Like Growth Factor I / metabolism
  • Lymphocytes / metabolism
  • Male
  • Receptors, Somatotropin / blood
  • Receptors, Somatotropin / genetics
  • Receptors, Somatotropin / metabolism*

Substances

  • Receptors, Somatotropin
  • Insulin-Like Growth Factor I